Centers for Medicare & Medicaid Services said on Wednesday it has extended key application deadlines for drugmakers and ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results